187 related articles for article (PubMed ID: 38152968)
21. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
Lin J; Wang Y; Wang Y; Pan Y
Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
[No Abstract] [Full Text] [Related]
23. Independent Causal Effect of Remnant Cholesterol on Atherosclerotic Cardiovascular Outcomes: A Mendelian Randomization Study.
Navarese EP; Vine D; Proctor S; Grzelakowska K; Berti S; Kubica J; Raggi P
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):e373-e380. PubMed ID: 37439258
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
[TBL] [Abstract][Full Text] [Related]
25. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
26. Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.
Pott J; Schlegel V; Teren A; Horn K; Kirsten H; Bluecher C; Kratzsch J; Loeffler M; Thiery J; Burkhardt R; Scholz M
Circ Genom Precis Med; 2018 May; 11(5):e001992. PubMed ID: 29748315
[TBL] [Abstract][Full Text] [Related]
27. Cardiac Risk Factors for Stroke: A Comprehensive Mendelian Randomization Study.
Frerich S; Malik R; Georgakis MK; Sinner MF; Kittner SJ; Mitchell BD; Dichgans M
Stroke; 2022 Apr; 53(4):e130-e135. PubMed ID: 34911345
[TBL] [Abstract][Full Text] [Related]
28. Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits.
Park JK; Bafna S; Forrest IS; Duffy Á; Marquez-Luna C; Petrazzini BO; Vy HM; Jordan DM; Verbanck M; Narula J; Rosenson RS; Rocheleau G; Do R
Elife; 2023 Mar; 12():. PubMed ID: 36988189
[TBL] [Abstract][Full Text] [Related]
29. Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.
Sjaarda J; Gerstein H; Chong M; Yusuf S; Meyre D; Anand SS; Hess S; Paré G
J Am Coll Cardiol; 2018 Jul; 72(3):300-310. PubMed ID: 30012324
[TBL] [Abstract][Full Text] [Related]
30. Effects of obesity-related anthropometric indices and body composition on erectile dysfunction mediated by coronary artery disease: A Mendelian randomization study.
Bao B; Guo J; Zhang L; Pan Z; Huang H; Qin Z; Chen L; Zhou X; Liu B
Andrology; 2024 Jan; 12(1):75-86. PubMed ID: 37082877
[TBL] [Abstract][Full Text] [Related]
31. Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
De Marchis GM; Dittrich TD; Malik R; Zietz AV; Kriemler LF; Ference BA; Dichgans M; Georgakis MK
Atherosclerosis; 2022 Nov; 361():41-46. PubMed ID: 36244797
[TBL] [Abstract][Full Text] [Related]
32. Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.
Kang X; Jiao T; Wang H; Pernow J; Wirdefeldt K
EBioMedicine; 2022 Feb; 76():103824. PubMed ID: 35074627
[TBL] [Abstract][Full Text] [Related]
33. Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.
Liu Z; Wang H; Yang Z; Lu Y; Zou C
Cardiovasc Diabetol; 2023 Sep; 22(1):236. PubMed ID: 37659996
[TBL] [Abstract][Full Text] [Related]
34. Sex-Specific Reproductive Factors Augment Cardiovascular Disease Risk in Women: A Mendelian Randomization Study.
Ardissino M; Slob EAW; Carter P; Rogne T; Girling J; Burgess S; Ng FS
J Am Heart Assoc; 2023 Mar; 12(5):e027933. PubMed ID: 36846989
[TBL] [Abstract][Full Text] [Related]
35. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
[TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization study of the effect of coronary artery calcification on atherosclerotic cardiovascular diseases.
Sae-Jie W; Tangcharoen T; Vathesatogkit P; Aekplakorn W; Charoen P
Sci Rep; 2022 Sep; 12(1):14829. PubMed ID: 36050433
[TBL] [Abstract][Full Text] [Related]
37. Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.
Manousaki D; Mokry LE; Ross S; Goltzman D; Richards JB
Circ Cardiovasc Genet; 2016 Aug; 9(4):349-56. PubMed ID: 27418593
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Donovan K; Herrington WG; Paré G; Pigeyre M; Haynes R; Sardell R; Butterworth AS; Folkersen L; Gustafsson S; Wang Q; Baigent C; Mälarstig A; Holmes MV; Staplin N;
Clin J Am Soc Nephrol; 2023 Jan; 18(1):17-27. PubMed ID: 36719157
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease.
Sharma P; Klarin D; Voight BF; Tsao PS; Levin MG; Damrauer SM
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1114-1123. PubMed ID: 38545784
[TBL] [Abstract][Full Text] [Related]
40. Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis.
Gill D; Georgakis MK; Zuber V; Karhunen V; Burgess S; Malik R; Dichgans M
J Am Heart Assoc; 2020 Jul; 9(14):e016773. PubMed ID: 32627641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
